Elsevier

Epilepsy Research

Volume 70, Issue 1, July 2006, Pages 89-94
Epilepsy Research

Short communication
Cognition and behavior in children with benign epilepsy with centrotemporal spikes (BECTS)

https://doi.org/10.1016/j.eplepsyres.2006.02.005Get rights and content

Abstract

Characteristics of cognitive deficits in benign childhood epilepsy with centrotemporal spikes (BECTS) remain unclear. The authors screened 200 BECTS children presenting for a clinical trial, finding relative weaknesses in fine motor control, visual learning, and attention in the presence of overall normal intellect, with simple partial seizures associated with more difficulty. Parental concerns for psychosomatic and learning problems were noted. Monitoring select cognitive and behavioral features in BECTS appears appropriate.

Introduction

Benign childhood epilepsy with centrotemporal spikes (BECTS) is one of the most common forms of childhood epilepsies with published prevalence rates ranging from 10 to 24% (Bouma et al., 1997, Cavazzuti, 1980, Hauser, 1994, Lerman, 1992, Loiseau et al., 1991). BECTS is slightly more frequent in boys (58.2%) (Bouma et al., 1997). Seizure frequency is low, typically 2–5 total seizures, but also quite variable, ranging from a single lifetime episode to multiple seizures per day (Bouma et al., 1997). BECTS prognosis is excellent, with 98% of children outgrowing the disorder by puberty (Bouma et al., 1997).

Normal neurologic and psychological findings are usually reported, although some studies suggest a link between BECTS and visuomotor, attention, language, memory, and behavior difficulties (Croona et al., 1999, Dalessandro et al., 1990, Heijbel and Bohman, 1975, Staden et al., 1998, Weglage et al., 1997). While this raises questions about the benign nature of BECTS, small sample sizes, potential confounds of sample bias and antiepileptic drug (AED) effects make definitive conclusions premature. Understanding cognitive and behavioral co-morbidities, even in the context of a relatively benign seizure disorder, remains an important area of concern, which we have approached in a relatively large sample of children with BECTS.

Section snippets

Methods

Subjects were 200 children (115 males, 57.5%) completing brief psychometric screens prior to the treatment phase of a 49 center, double-blind, placebo-controlled study of gabapentin. Ages ranged from 4 to 13 years, with grade placement from kindergarten to seventh. Thirty-one (15.5%) children were in special education. Ten (5.0%) were taking attention deficit/hyperactivity disorder (ADHD) medication.

Inclusion criteria were: (a) diagnosis of BECTS with partial or secondarily generalized

Results

BECTS with simple partial seizures was found in 20% of the children. Twenty-one percent had complex partial seizures, and the remaining 59% had secondarily generalized tonic–clonic seizures. AED use was found in 34% of children, and percentages did not differ across seizure types (χ2 = 0.75, p = 0.69). The three seizure groups did not differ significantly in age (F = 1.56, p = 0.21), education (F = 0.82, p = 0.44), distribution of special education (χ2 = 0.20, p = 0.90), or the number of seizures in the past

Discussion

Data from this large sample of children with BECTS are consistent with previous findings of higher incidence in males and generally average intellect. At the same time, our data suggest some evidence for select cognitive and behavioral difficulties compared to normative populations. Specifically, BECTS children performed worst on a subtest reflecting verbal attention, number/letter, with the next lowest score being on a visual attention subtest, finger windows, consistent with other findings

Acknowledgements

The authors wish to thank the site primary investigators and coordinators of this multicenter trial for their assistance with data collection.

This research was sponsored by a grant from Pfizer Pharmaceuticals Inc., Global Research Division. Drs. Garofalo and Sharma were employees of this company at the time that this study was conducted. Dr. Giordani has received limited consultation fees from this company. Dr. Giordani's spouse is employed by the company, thus, the family holds stock options

References (12)

  • D. Ott et al.

    Measures of psychopathology in children with complex partial seizures and primary generalized epilepsy with absence

    J. Am. Acad. Child Adolescent Psychiatry

    (2001)
  • P.A.D. Bouma et al.

    The course of benign partial epilepsy of childhood with centrotemporal spikes: a meta-analysis

    Neurology

    (1997)
  • G.B. Cavazzuti

    Epidemiology of different types of epilepsy in school age children of Modena, Italy 1

    Epilepsia

    (1980)
  • C. Croona et al.

    Neuropsychological findings in children with benign childhood epilepsy with centrotemporal spikes

    Dev. Med. Child Neurol.

    (1999)
  • P. Dalessandro et al.

    Neuropsychological features of benign partial epilepsy in children

    Ital. J. Neurol. Sci.

    (1990)
  • B. Giordani

    Intellectual and cognitive disturbances in epileptic patients

There are more references available in the full text version of this article.

Cited by (71)

  • The attentional networks in benign epilepsy with centrotemporal spikes

    2015, Epilepsy and Behavior
    Citation Excerpt :

    Initially, BECTS was considered as a benign epilepsy with no comorbidity associated with it. However, the “benign” nature of BECTS has been recently called into question because of cognitive and behavioral impairments, for example speech and sound disorders, language disabilities, and memory deficit, which are frequently observed in children with BECTS [2–5]. The most important behavioral impairment is an attentional problem that could seriously impact the learning process and the living condition of patients, even when the seizures have remitted [6].

View all citing articles on Scopus
1

Tel.: +1 734 764 7384; fax: +1 734 936 9262.

2

Tel.: +1 262 241 5955x206; fax: +1 262 241 5926.

3

Tel.: +1 517 337 9554; fax: +1 517 337 9545.

4

Tel.: +1 734 936 5972; fax: +1 734 936 9262.

5

Tel.: +1 734 622 3260; fax: +1 734 622 3406.

6

Tel.: +1 248 538 1800; fax: +1 248 538 1801.

7

Tel.: +1 734 622 7567; fax: +1 734 622 2856.

View full text